Routine filing of SEBI Regulation 74(5) certificate for Q2 FY27

Compliance View source PDF Explain this filing

SHEEL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹59.55

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+6.6% vs market

On the reaction day the stock moved 6.6 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

+5.0-1.6+6.6

Next day

—-1.0—

—-2.6—

+0.8-5.1+6.0

+0.8-6.1+7.0

-1.0-8.3+7.3

-1.4pendingpending

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sheel Biotech has submitted a certificate from its Registrar and Share Transfer Agent, Skyline Financial Services, under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The RTA confirms that no physical share certificates were received for dematerialization of equity shares during the quarter. This is a standard regulatory compliance submission required by SEBI Depositories Regulations.

Likely market impact

No material impact. Routine quarterly compliance filing; confirms no physical shares were submitted for demat conversion in Q2 FY27.